Impact Partnership Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.38M Buy
48,231
+37,482
+349% +$997K 0.12% 123
2026
Q2
$259K Buy
10,749
+349
+3% +$9.13K 0.03% 370
2026
Q1
$292K Sell
10,400
-20,422
-66% -$544K 0.04% 278
2025
Q4
$767K Buy
30,822
+6,823
+28% +$172K 0.1% 138
2025
Q3
$611K Buy
+23,999
New +$592K 0.09% 139
2024
Q2
– Sell
-882
Closed -$24.5K – 541
2024
Q1
$24.5K Sell
882
-905
-51% -$25.1K 0.01% 372
2023
Q4
$51.5K Sell
1,787
-19,392
-92% -$586K 0.02% 319
2023
Q3
$703K Buy
21,179
+12,754
+151% +$451K 0.22% 51
2023
Q2
$309K Buy
+8,425
New +$328K 0.11% 137

Other funds holding PFE

Impact Partnership Wealth's PFE Position: Q3 2026 in Review

Impact Partnership Wealth increased its Pfizer (PFE) stake by 349% in Q3 2026, buying an estimated $997K and bringing the position to 48,231 shares worth $1.38M. The position accounts for 0.12% of the portfolio, ranked #123.

Impact Partnership Wealth first reported a position in PFE in Q2 2023 and has held it in 9 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Impact Partnership Wealth held 48,231 shares of Pfizer worth $1.38M as of Q3 2026.
  • Impact Partnership Wealth bought 37,482 Pfizer shares in Q3 2026, an estimated $997K.
  • Pfizer made up 0.12% of Impact Partnership Wealth's portfolio in Q3 2026, its #123 holding.
  • Impact Partnership Wealth first reported a position in Pfizer in Q2 2023 and has held it in 9 quarters since.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Impact Partnership Wealth's 13F filing for Q3 2026, filed 9 Nov 2026.